share_log

AI/ML Innovations Inc. Announces Agreement With Moonshot Inc.

AI/ML Innovations Inc. Announces Agreement With Moonshot Inc.

AI/ML Innovations Inc.宣佈與Moonshot Inc.達成協議
Accesswire ·  05/18 05:30

TORONTO, ON / ACCESSWIRE / May 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has entered into an independent contractor agreement (the "Agreement") with Moonshot Inc. (the "Contractor") to set out the terms and conditions of the Contactor's ongoing services to be provided to the Company (the "Services"). The Services will generally consist of the Contractor providing the services of Paul Duffy to serve as the Company's Chief Executive Officer. The Services will include such services and duties as would be generally associated with such a position.

安大略省多倫多/ACCESSWIRE/2024年5月17日/AI/ML Innovations Inc.(“AI/ML” 或 “公司”)(CSE: AIML)(OTCQB: AIMLF)(FWB: 42FB)欣然宣佈,它已與Moonshot Inc.(“承包商”)簽訂了獨立承包商協議(“協議”),以規定承包商的條款和條件向公司提供的持續服務(“服務”)。服務通常包括承包商提供保羅·達菲的服務,擔任公司的首席執行官。這些服務將包括與此類職位通常相關的服務和職責。

In consideration for performing the Services to the Company, the Company will pay the Contractor a signing bonus, payable to or as directed by the Executive as follows,

作爲向公司提供服務的報價,公司將向承包商支付簽約獎金,該獎金應支付給行政部門或按照行政部門的指示,如下所示,

i) $125,000 payable in common shares in the capital of the Company ("Shares") on the Effective Date; and

i) 生效之日公司資本中應付的12.5萬美元普通股(“股份”);以及

ii) $125,000 payable in Shares on the second anniversary of the Start Date;

ii) 在開始日期兩週年之際以股份形式支付的12.5萬美元;

In addition to monthly fees, the company will also pay annual retention fees of $250,000 and $300,000 over the first 2 years of the Agreement, payable quarterly in Shares.

除了月費外,該公司還將在協議的前兩年支付25萬美元的年度留存費和300,000美元,每季度以股票形式支付。

Any Shares issued to the Contractor shall be issued at a price per share equal ‎to the greater of $0.05 or the fair market value at the time of issuance, except for Shares issued as of the Effective Date which will be issued at $0.075. All Shares are subject to a hold period.

向承包商發行的任何股票均應按每股價格發行‎to(以0.05美元或發行時的公允市場價值中較高者爲準),但截至生效日發行的股票除外,其發行價格爲0.075美元。所有股票都有持有期。

Upon signing of the Agreement, the Company also granted to the Contractor options to purchase up to 1,500,000 Shares with an exercise price of $0.20 per Share and a term of five years (the "Options"). The Options shall vest in three equal installments contingent on the Company achieving given milestones, as defined in the Agreement.

協議簽署後,公司還授予承包商購買最多1,500,000股股票的期權,行使價爲每股0.20美元,期限爲五年(“期權”)。期權應分三次等額分期歸屬,視公司實現協議中規定的給定里程碑而定。

The issuance of the Shares and the Options are subject to the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.

股票和期權的發行必須獲得所有必要的批准,包括加拿大證券交易所的批准。

For more information about AI/ML Innovations:

有關 AI/ML 創新的更多信息:

For detailed information please see AI/ML's website or the Company's filed documents at .

有關詳細信息,請參閱AI/ML的網站或公司提交的文件,網址爲。

For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

欲了解更多信息,請致電 (778) 405-0882 或 info@aiml-innovations.com 與 Blake Fallis 聯繫。

About AI/ML Innovations Inc.

關於 AI/ML Innovations Inc

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Heal (22% ownership commitment by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

AI/ML Innovations Inc.已調整其業務運營,以充分利用新興的人工智能(AI)和機器學習(ML)領域,初始投資重點是新興的數字健康和福祉公司,這些公司利用人工智能、機器學習、雲計算和數字平台推動變革性醫療管理解決方案和整個健康領域的精準支持。通過與Health Gauge(AIML持有70%的股權)、Tech2Heal(AIML承諾22%的所有權)、AI Rx Inc.(AIML持有70%的股權)的戰略合作伙伴關係以及其他計劃中的增值投資,公司繼續利用不斷擴大的增長領域,使公司的所有利益相關者受益。AI/ML的股票在加拿大證券交易所上市,股票代碼爲 “AIML”,OTCQB風險市場交易代碼爲 “AIMLF”,在法蘭克福證券交易所上市,股票代碼爲 “42FB”。

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

代表董事會
蒂姆·丹尼爾斯,執行主席

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

CSE及其監管服務提供商(該術語在CSE的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

SOURCE: AI/ML Innovations Inc.

來源:AI/ML Innovations Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論